Tradestie Institutional Equity Comparison Engine
ABVX vs UYSC โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
UYSC Overall Edge
UYSC Captures Institutional Edge (3โ1 Pillars ยท 7โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to UYSC (UYSC) driven by superior Valuation, Growth & Margin, Momentum & Technical while ABVX counters with relative strength in Options & Structure. Fundamentally, ABVX trades at N/M Forward P/E with -6270.4% operating margin (-6.8% YoY revenue) versus UYSC at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, ABVX sits in UNCLASSIFIED (<1st %ile IV; Dealer Gamma Walls on Pro) against UYSC sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
UYSC
ABVX N/M vs UYSC N/M Fwd P/E
Growth & Margin Winner
UYSC
Op Margin -6270.4% vs 0.0% ยท YoY -6.8% vs +0.0%
Momentum & Technical Winner
UYSC
1Y -35.2% vs +10.5% ยท 52W Pos 12% vs 62%
Options & Structure Winner
ABVX
UNCLASSIFIED (<1st %ile IV) vs UNCLASSIFIED (N/A IV)
ABVX
NASDAQ
Abivax SA American Depositary Shares
Pharmaceutical Preparations
$73.20
-9.24% 1D
Market Cap
$7.1B
1M Return
-18.87%
1Y Return
-35.19%
Forward P/E
N/M
Unified AI Score
42.4 / 100
HOLD
Tech 25.0
Fund 38.0
Flow 50.0
Mom 30.0
UYSC
US Equity
UYSC
Institutional Equity
$11.04
+0.0% 1D
Market Cap
$84.2M
1M Return
+3.18%
1Y Return
+10.51%
Forward P/E
N/M
Unified AI Score
51.5 / 100
HOLD
Tech 45.0
Fund 47.0
Flow 50.0
Mom 46.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
ABVX -35.19%
UYSC +10.51%
Spread: +28.45 pp (UYSC Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
ABVX TTM Op. Margin: -6270.4%
UYSC TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ABVX vs UYSC. Trailing 12-month operating profitability (ABVX -6270.4% vs UYSC 0.0%) and valuation multiples (ABVX N/M vs UYSC N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | ABVX | UYSC | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $7.1B | $84.2M | Larger Scale | ABVX |
| Trailing P/E Ratio Valuation | N/M | 35.5x | Lower Multiple | UYSC |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | -6.8% | +0.0% | Higher Growth | UYSC |
| Operating Margin (TTM) Profitability | -6270.4% | 0.0% | Higher Margin | UYSC |
| Net Profit Margin Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | -252.3% | 38.2% | Higher ROE | UYSC |
| 52-Week Range Position Momentum | 12% ($63โ$149) | 62% ($10โ$12) | Stronger Trend | UYSC |
| Beta / 30D Volatility Risk Regime | 1.55ฮฒ ยท 55% Vol | -0.01ฮฒ ยท 7% Vol | Lower Realized Risk | UYSC |
| Unified Institutional Score Composite Signal | 42.4 / 100 (HOLD) | 51.5 / 100 (HOLD) | Higher Composite | UYSC |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full ABVX vs UYSC Buy Guide
ABVX
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
<1st %ile
IV Regime
Compressed (<25th %ile)
UYSC
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither ABVX nor UYSC registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.